# Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

> **NCT00051545** · PHASE3 · TERMINATED · sponsor: **LEO Pharma** · enrollment: 608 (—)

## Conditions studied

- Liver Neoplasms

## Interventions

- **DRUG:** Seocalcitol

## Key facts

- **NCT ID:** NCT00051545
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-11
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 608 (—)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00051545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00051545, "Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00051545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*